IMO if we receive positive news in October area, that will allow for many more opportunities for the other products and technologies that ACTC has. This is possibly the flag stone for a new paradigm of medicine. Perhaps the company is wait for the results, before the move on to introduce other PR's?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.